Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy
Sign Up to like & getrecommendations! Published in 2021 at "Renal Failure"
DOI: 10.1080/0886022x.2021.1937219
Abstract: Abstract Diabetic glomerulopathy (DG) remains the prevalent microvascular complication and leading cause of shortened lifespan in type-2 diabetes mellitus (T2DM) despite improvement in hyperglycemia control. Considering the pivotal role of kidney in metabolism, using untargeted… read more here.
Keywords: diabetic glomerulopathy; metabolomics tryptophan; metabolism; untargeted serum ... See more keywords
Untargeted serum metabolomics reveals specific metabolite abnormalities in patients with Crohn's disease
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.814839
Abstract: Crohn's disease (CD) is a subtype of inflammatory bowel disease (IBD) characterized by skip intestinal lesions that can occur in any part of the gastrointestinal tract. Currently, the diagnosis of CD is based on clinical… read more here.
Keywords: disease; healthy controls; crohn disease; untargeted serum ... See more keywords
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.938234
Abstract: Metabolomics has been reported as an efficient tool to screen biomarkers that are related to esophageal cancer. However, the metabolic biomarkers identifying malignant degrees and therapeutic efficacy are still largely unknown in the disease. Here,… read more here.
Keywords: esophageal cancer; metabolomics reveals; untargeted serum; serum metabolomics ... See more keywords